Next Financial Group’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$99K Buy
695
+469
+208% +$80.6K 0.01% 1169
2021
Q3
$47K Buy
226
+151
+201% +$33.3K ﹤0.01% 1436
2021
Q2
$16K Hold
75
﹤0.01% 1835
2021
Q1
$14K Sell
75
-9
-11% -$1.79K ﹤0.01% 1769
2020
Q4
$9K Sell
84
-53
-39% -$5.63K ﹤0.01% 1815
2020
Q3
$15K Buy
+137
New +$16.7K ﹤0.01% 1513
2020
Q2
Sell
-1,000
Closed -$14K 1460
2020
Q1
$14K Buy
+1,000
New +$8.46K ﹤0.01% 1406
2017
Q1
Sell
-380
Closed -$10K 2152
2016
Q4
$10K Buy
+380
New +$11.1K ﹤0.01% 1657
2014
Q4
Hold
0
2201
2014
Q3
Hold
0
2547

Other funds holding NVAX

Next Financial Group's NVAX Position: Q4 2021 in Review

Next Financial Group increased its Novavax (NVAX) stake by 208% in Q4 2021, buying an estimated $80.6K and bringing the position to 695 shares worth $99K. The position accounts for 0.01% of the portfolio, ranked #1169.

Next Financial Group first reported a position in NVAX in Q4 2016 and has held it in 8 quarters since. 429 funds tracked by Wall St. Rank hold NVAX as of Q4 2021.

  • Next Financial Group held 695 shares of Novavax worth $99K as of Q4 2021.
  • Next Financial Group bought 469 Novavax shares in Q4 2021, an estimated $80.6K.
  • Novavax made up 0.01% of Next Financial Group's portfolio in Q4 2021, its #1169 holding.
  • Next Financial Group first reported a position in Novavax in Q4 2016 and has held it in 8 quarters since.
  • 429 funds tracked by Wall St. Rank held Novavax as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.